Adiponectin as an anti-inflammatory factor in the pathogenesis of psoriasis: induction of elevated serum adiponectin levels following therapy

Br J Dermatol. 2011 Mar;164(3):667-70. doi: 10.1111/j.1365-2133.2010.10123.x. Epub 2011 Feb 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Adiponectin / blood*
  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Psoriatic / blood
  • Arthritis, Psoriatic / drug therapy
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Infliximab
  • Interleukin-6 / blood
  • Male
  • Middle Aged
  • Psoriasis / blood*
  • Psoriasis / drug therapy
  • Severity of Illness Index
  • Ultraviolet Therapy / methods

Substances

  • Adiponectin
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-6
  • Infliximab
  • Adalimumab